The Application of Adjuvant Radiotherapy in pN1 OSCC Patients Without Adverse Pathologic Features
Adjuvant radiotherapy does not improve the prognosis of T1-2N1M0 patients without adverse pathological features; however, adjuvant radiotherapy should be recommended for T3-4aN1M0 patients.
Authors
- Zhien Feng (ORCID: https://orcid.org/0000-0003-1952-6734)
- Hanchen Zhou (ORCID: https://orcid.org/0000-0002-9844-5029)
- Wei Cao (ORCID: https://orcid.org/0000-0003-2184-9380)
- Yu Huang (ORCID: https://orcid.org/0000-0003-1500-0989)
- Wei Wei (ORCID: https://orcid.org/0000-0002-8008-8895)
- Bo Li (ORCID: https://orcid.org/0000-0002-1040-1540)
- Zhao Zhang (ORCID: https://orcid.org/0000-0002-3312-4849)
- Xue Zhang (ORCID: https://orcid.org/0000-0001-7593-6717)
- Na Ge (ORCID: https://orcid.org/0000-0003-4913-1469)
- Chuanbin Guo
Institutions
- Shanghai Jiao Tong University (CN)
- Capital Medical University (CN)
- Peking University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Shanghai Ninth People's Hospital (CN)
- Beijing Friendship Hospital (CN)
- Beijing Obstetrics and Gynecology Hospital (CN)
Publication Details
- Journal
- Oral Diseases
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1111/odi.15336
- Citations
- 4
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 7.39
Funders
- National Natural Science Foundation of China
- Capital Medical University
- Beijing Nova Program